Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro

por DeChristopher, Brian A., Loy, Brian A., Marsden, Matthew D., Schrier, Adam J., Zack, Jerome A., Wender, Paul A.
Publicado 2012

REDOR NMR Reveals Multiple Conformers for a Protein Kinase C Ligand in a Membrane Environment

por Yang, Hao, Staveness, Daryl, Ryckbosch, Steven M., Axtman, Alison D., Loy, Brian A., Barnes, Alexander B., Pande, Vijay S., Schaefer, Jacob, Wender, Paul A., Cegelski, Lynette
Publicado 2018

Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death

por Staveness, Daryl, Abdelnabi, Rana, Schrier, Adam J., Loy, Brian A., Verma, Vishal A., DeChristopher, Brian A., Near, Katherine E., Neyts, Johan, Delang, Leen, Leyssen, Pieter, Wender, Paul A.
Publicado 2016

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

por Marsden, Matthew D., Loy, Brian A., Wu, Xiaomeng, Ramirez, Christina M., Schrier, Adam J., Murray, Danielle, Shimizu, Akira, Ryckbosch, Steven M., Near, Katherine E., Chun, Tae-Wook, Wender, Paul A., Zack, Jerome A.
Publicado 2017

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

por Marsden, Matthew D., Wu, Xiaomeng, Navab, Sara M., Loy, Brian A., Schrier, Adam J., DeChristopher, Brian A., Shimizu, Akira J., Hardman, Clayton T., Ho, Stephen, Ramirez, Christina M., Wender, Paul A., Zack, Jerome A.
Publicado 2018